![]() | |
Clinical data | |
---|---|
Other names | Pyrroxane, Pirroksan |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C21H23NO3 |
Molar mass | 337.419 g·mol−1 |
3D model ( JSmol) | |
| |
|
Proroxan ( INN; also known as pyrroxane and pirroksan) is a pharmaceutical drug used as an antihypertensive and in the treatment of Ménière's disease, motion sickness, and allergic dermatitis. [1] [2]
Proroxan is a non-selective alpha-blocker (α-adrenoreceptor antagonist). [1]
Proroxan was developed in the 1970s at the Institute of Toxicology of the USSR Ministry of Health [3] and today is primarily used in Russia. Though originally developed as an antihypertensive, its use can lead to a decrease in alcohol and drug consumption. Currently proroxan is used almost exclusively in psychiatry, narcology, and neurology. [3]
![]() | |
Clinical data | |
---|---|
Other names | Pyrroxane, Pirroksan |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C21H23NO3 |
Molar mass | 337.419 g·mol−1 |
3D model ( JSmol) | |
| |
|
Proroxan ( INN; also known as pyrroxane and pirroksan) is a pharmaceutical drug used as an antihypertensive and in the treatment of Ménière's disease, motion sickness, and allergic dermatitis. [1] [2]
Proroxan is a non-selective alpha-blocker (α-adrenoreceptor antagonist). [1]
Proroxan was developed in the 1970s at the Institute of Toxicology of the USSR Ministry of Health [3] and today is primarily used in Russia. Though originally developed as an antihypertensive, its use can lead to a decrease in alcohol and drug consumption. Currently proroxan is used almost exclusively in psychiatry, narcology, and neurology. [3]